Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 255

1.

A network intervention that locates and intervenes with recently HIV-infected persons: The Transmission Reduction Intervention Project (TRIP).

Nikolopoulos GK, Pavlitina E, Muth SQ, Schneider J, Psichogiou M, Williams LD, Paraskevis D, Sypsa V, Magiorkinis G, Smyrnov P, Korobchuk A, Vasylyeva TI, Skaathun B, Malliori M, Kafetzopoulos E, Hatzakis A, Friedman SR.

Sci Rep. 2016 Dec 5;6:38100. doi: 10.1038/srep38100.

2.

Reducing HIV infection in people who inject drugs is impossible without targeting recently-infected subjects.

Vasylyeva TI, Friedman SR, Lourenco J, Gupta S, Hatzakis A, Pybus OG, Katzourakis A, Smyrnov P, Karamitros T, Paraskevis D, Magiorkinis G.

AIDS. 2016 Nov 28;30(18):2885-2890.

3.

Utility and applicability of the "Childhood Obesity Risk Evaluation" (CORE)-index in predicting obesity in childhood and adolescence in Greece from early life: the "National Action Plan for Public Health".

Manios Y, Vlachopapadopoulou E, Moschonis G, Karachaliou F, Psaltopoulou T, Koutsouki D, Bogdanis G, Carayanni V, Hatzakis A, Michalacos S.

Eur J Pediatr. 2016 Dec;175(12):1989-1996.

PMID:
27796510
4.

Evaluation of the limiting antigen avidity EIA (LAg) in people who inject drugs in Greece.

Nikolopoulos GK, Katsoulidou A, Kantzanou M, Rokka C, Tsiara C, Sypsa V, Paraskevis D, Psichogiou M, Friedman S, Hatzakis A.

Epidemiol Infect. 2016 Oct 26:1-12. [Epub ahead of print]

PMID:
27780490
5.

Analytical characteristics and comparative evaluation of Aptima HIV-1 Quant Dx assay with Ampliprep/COBAS TaqMan HIV-1 test v2.0.

Hatzakis A, Papachristou H, Nair SJ, Fortunko J, Foote T, Kim H, Peling TL, Worlock AJ.

Virol J. 2016 Oct 21;13(1):176.

6.

HCV dispersal patterns among intravenous drug users (IDUs) in Athens metropolitan area.

Papachristou E, Tsagkovits A, Zavitsanou A, Hatzakis A, Paraskevis D.

Infect Genet Evol. 2016 Nov;45:415-419. doi: 10.1016/j.meegid.2016.10.003.

PMID:
27721034
7.

A contaminant-free assessment of Endogenous Retroviral RNA in human plasma.

Karamitros T, Paraskevis D, Hatzakis A, Psichogiou M, Elefsiniotis I, Hurst T, Geretti AM, Beloukas A, Frater J, Klenerman P, Katzourakis A, Magiorkinis G.

Sci Rep. 2016 Sep 19;6:33598. doi: 10.1038/srep33598.

8.

Is elimination of HCV possible in a country with low diagnostic rate and moderate HCV prevalence? The case of Greece.

Gountas I, Sypsa V, Papatheodoridis G, Souliotis K, Razavi H, Hatzakis A.

J Gastroenterol Hepatol. 2016 Jul 12. doi: 10.1111/jgh.13485. [Epub ahead of print]

PMID:
27403912
9.

Molecular epidemiology of HIV-1 infection in Europe: An overview.

Beloukas A, Psarris A, Giannelou P, Kostaki E, Hatzakis A, Paraskevis D.

Infect Genet Evol. 2016 Dec;46:180-189. doi: 10.1016/j.meegid.2016.06.033.

PMID:
27321440
10.

The application of HIV molecular epidemiology to public health.

Paraskevis D, Nikolopoulos GK, Magiorkinis G, Hodges-Mameletzis I, Hatzakis A.

Infect Genet Evol. 2016 Dec;46:159-168. doi: 10.1016/j.meegid.2016.06.021.

PMID:
27312102
11.

The global spread of HIV-1 subtype B epidemic.

Magiorkinis G, Angelis K, Mamais I, Katzourakis A, Hatzakis A, Albert J, Lawyer G, Hamouda O, Struck D, Vercauteren J, Wensing A, Alexiev I, Åsjö B, Balotta C, Gomes P, Camacho RJ, Coughlan S, Griskevicius A, Grossman Z, Horban A, Kostrikis LG, Lepej SJ, Liitsola K, Linka M, Nielsen C, Otelea D, Paredes R, Poljak M, Puchhammer-Stöckl E, Schmit JC, Sönnerborg A, Staneková D, Stanojevic M, Stylianou DC, Boucher CA; SPREAD program., Nikolopoulos G, Vasylyeva T, Friedman SR, van de Vijver D, Angarano G, Chaix ML, de Luca A, Korn K, Loveday C, Soriano V, Yerly S, Zazzi M, Vandamme AM, Paraskevis D.

Infect Genet Evol. 2016 Dec;46:169-179. doi: 10.1016/j.meegid.2016.05.041.

12.

Biological Warfare Plan in the 17th Century—the Siege of Candia, 1648–1669.

Thalassinou E, Tsiamis C, Poulakou-Rebelakou E, Hatzakis A.

Emerg Infect Dis. 2015 Dec;21(12):2148-53.

13.

Addressing barriers to the prevention, diagnosis and treatment of hepatitis B and C in the face of persisting fiscal constraints in Europe: report from a high level conference.

Papatheodoridis G, Thomas HC, Golna C, Bernardi M, Carballo M, Cornberg M, Dalekos G, Degertekin B, Dourakis S, Flisiak R, Goldberg D, Gore C, Goulis I, Hadziyannis S, Kalamitsis G, Kanavos P, Kautz A, Koskinas I, Leite BR, Malliori M, Manolakopoulos S, Matičič M, Papaevangelou V, Pirona A, Prati D, Raptopoulou-Gigi M, Reic T, Robaeys G, Schatz E, Souliotis K, Tountas Y, Wiktor S, Wilson D, Yfantopoulos J, Hatzakis A.

J Viral Hepat. 2016 Feb;23 Suppl 1:1-12. doi: 10.1111/jvh.12493.

PMID:
26809941
14.

Estimating HCV disease burden - volume 3 (editorial).

Aghemo A, Dore GJ, Hatzakis A, Wedemeyer H, Razavi H.

J Viral Hepat. 2015 Dec;22 Suppl 4:1-3. doi: 10.1111/jvh.12473. No abstract available.

PMID:
26513444
15.

Condom effectiveness in reducing heterosexual HIV transmission: a systematic review and meta-analysis of studies on HIV serodiscordant couples.

Giannou FK, Tsiara CG, Nikolopoulos GK, Talias M, Benetou V, Kantzanou M, Bonovas S, Hatzakis A.

Expert Rev Pharmacoecon Outcomes Res. 2016 Aug;16(4):489-99. doi: 10.1586/14737167.2016.1102635.

PMID:
26488070
16.

How do economic crises affect migrants' risk of infectious disease? A systematic-narrative review.

Kentikelenis A, Karanikolos M, Williams G, Mladovsky P, King L, Pharris A, Suk JE, Hatzakis A, McKee M, Noori T, Stuckler D.

Eur J Public Health. 2015 Dec;25(6):937-44. doi: 10.1093/eurpub/ckv151. Review.

17.

HBV-DNA levels predict overall mortality in HIV/HBV coinfected individuals.

Nikolopoulos GK, Paraskevis D, Psichogiou M, Hatzakis A.

J Med Virol. 2016 Mar;88(3):466-73. doi: 10.1002/jmv.24357.

PMID:
26288334
18.

Enhanced HIV-1 surveillance using molecular epidemiology to study and monitor HIV-1 outbreaks among intravenous drug users (IDUs) in Athens and Bucharest.

Paraskevis D, Paraschiv S, Sypsa V, Nikolopoulos G, Tsiara C, Magiorkinis G, Psichogiou M, Flampouris A, Mardarescu M, Niculescu I, Batan I, Malliori M, Otelea D, Hatzakis A.

Infect Genet Evol. 2015 Oct;35:109-21. doi: 10.1016/j.meegid.2015.08.004.

PMID:
26247720
19.

Dating the origin of hepatitis B virus reveals higher substitution rate and adaptation on the branch leading to F/H genotypes.

Paraskevis D, Angelis K, Magiorkinis G, Kostaki E, Ho SY, Hatzakis A.

Mol Phylogenet Evol. 2015 Dec;93:44-54. doi: 10.1016/j.ympev.2015.07.010.

PMID:
26220838
20.

Network Characteristics of People Who Inject Drugs Within a New HIV Epidemic Following Austerity in Athens, Greece.

Tsang MA, Schneider JA, Sypsa V, Schumm P, Nikolopoulos GK, Paraskevis D, Friedman SR, Malliori M, Hatzakis A.

J Acquir Immune Defic Syndr. 2015 Aug 1;69(4):499-508. doi: 10.1097/QAI.0000000000000665.

Items per page

Supplemental Content

Loading ...
Support Center